Julie Russom

Q: What is Julie Russom email address?

Email Julie Russom at julie.m.spirk@pfizer.com. This email is the most updated Julie Russom email found in 2026.

Q: How to contact Julie Russom?

To contact Julie Russom send an email to julie.m.spirk@pfizer.com. If you want to call Julie Russom try calling on +13143683420 and +16362471247.

Principal Scientist at Pfizer | St Louis, Missouri, United States

About Julie Russom

Julie Russom serves as a Principal Scientist at Pfizer, where she plays a pivotal role in the administration and optimization of enterprise laboratory data acquisition and management applications within the BioTherapeutics Pharmaceutical Science division. With a robust background in analytical chemistry and a deep understanding of Good Manufacturing Practices (GMP) and Good Laboratory Practice (GLP), Julie is instrumental in enhancing the efficiency and reliability of laboratory operations. Her expertise spans critical systems such as Electronic Laboratory Notebooks (ELN), Laboratory Information Management Systems (LIMS), and Chromatography Data Systems (CDS), where she not only serves as the Business System Owner but also takes on responsibilities as a business analyst, system administrator, trainer, and technical support specialist.

Julie’s current projects focus on streamlining data workflows and ensuring compliance with regulatory standards, which are essential for successful technology transfer and quality assurance in the pharmaceutical industry. Her ability to absorb and synthesize large volumes of technical information allows her to provide valuable insights and solutions to complex problems faced by both internal teams and external customers. By fostering strong relationships across departments, Julie effectively collaborates with engineers and scientists to align on mutual goals, driving innovation and operational excellence. Her personable approach and resourcefulness make her a key asset in navigating the challenges of modern pharmaceutical research and development, ensuring that Pfizer remains at the forefront of biotherapeutics advancements.

Julie Russom Work